{
 "name": "安特羅",
 "slug": "tw-6564",
 "aliases": [
  "安特羅生物科技股份有限公司",
  "ENIM",
  "6564"
 ],
 "ticker": "6564",
 "industry": "生技醫療業",
 "website": "www.enimmune.com.tw",
 "summary": "安特羅（6564）是興櫃的生技醫療類股公司，2014 年成立，2018 年登錄興櫃。基本資料取自臺灣證券交易所／證券櫃檯買賣中心公開資料；重大訊息見 https://drugnews.com.tw/filings/ 。",
 "facts": [
  {
   "claim": "公司全名",
   "value": "安特羅生物科技股份有限公司",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "英文簡稱",
   "value": "ENIM",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "產業類別",
   "value": "生技醫療業",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "掛牌市場",
   "value": "證券櫃檯買賣中心興櫃",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "登錄興櫃日期",
   "value": "2018-09-18",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "成立日期",
   "value": "2014-01-10",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "董事長",
   "value": "留忠正",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "總經理",
   "value": "張哲瑋",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "實收資本額",
   "value": 721340000,
   "unit": "新台幣元",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "簽證會計師事務所",
   "value": "資誠聯合會計師事務所",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "公司網址",
   "value": "www.enimmune.com.tw",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "管線：EV71（安拓伏腸病毒71型疫苗／EnVAX-A71）",
   "value": "預防2個月至未滿6歲幼兒腸病毒71型感染疾病｜已核准上市（許可證衛部菌疫製字000149）｜台灣",
   "unit": "",
   "as_of": "2023-04-11",
   "source": "https://www.fda.gov.tw/tc/includes/GetFile.ashx?cid=42959&id=f638168088767225421&type=2",
   "note": "TFDA核准審查摘要第1頁；as_of依TFDA審查摘要列表公開日期2023-04-11，核准日2023-01-18不同。"
  },
  {
   "claim": "管線：EV71（安拓伏腸病毒71型疫苗）",
   "value": "健康嬰幼童EV71疫苗有效性、免疫原性及安全性｜第III期已完成（2024-07-31）｜台灣、越南",
   "unit": "",
   "as_of": "2026-09-11",
   "source": "https://clinicaltrials.gov/api/v2/studies/NCT05099029",
   "note": "NCT05099029；ClinicalTrials.gov最後公開更新 2026-09-11；登錄狀態 COMPLETED。"
  },
  {
   "claim": "管線：EV71（EV-BR1701 Part A1延伸研究）",
   "value": "EV71疫苗接種後免疫持續性追蹤｜觀察性延伸研究已完成（2026-04-22），不屬新增藥證｜台灣",
   "unit": "",
   "as_of": "2026-06-10",
   "source": "https://clinicaltrials.gov/api/v2/studies/NCT07635966",
   "note": "NCT07635966；ClinicalTrials.gov最後公開更新 2026-06-10；登錄狀態 COMPLETED。"
  },
  {
   "claim": "管線：EV71（EV-BR1701 Group B1延伸研究）",
   "value": "EV71疫苗接種後免疫持續性追蹤｜觀察性延伸研究已完成（2025-09-09），不屬新增藥證｜越南",
   "unit": "",
   "as_of": "2026-09-11",
   "source": "https://clinicaltrials.gov/api/v2/studies/NCT07630493",
   "note": "NCT07630493；ClinicalTrials.gov最後公開更新 2026-09-11；登錄狀態 COMPLETED。"
  },
  {
   "claim": "管線：EV71（安拓伏／EnVAX-A71）",
   "value": "預防2個月至未滿6歲嬰幼兒腸病毒71型感染疾病｜新藥查驗登記已核准並取得藥證｜澳門",
   "unit": "",
   "as_of": "2026-03-30",
   "source": "https://mops.twse.com.tw/mops/#/web/t05st01",
   "note": "發言日期115/03/30 19:00:03，6564、序號2；主旨：本公司安拓伏腸病毒71型疫苗(EnVAX-A71)通過澳門藥物監督管理局「藥物(西藥)」新藥查驗登記核准，取得腸病毒疫苗藥證。"
  }
 ],
 "responses": [],
 "provided_by": "public_sources",
 "verified_by": "Drugnews｜藥時事",
 "verified_at": "2026-10-22",
 "disclosure": "Drugnews 依公開來源（公司公告、公開資訊觀測站、試驗登錄、主管機關文件）整理，於 verified_at 逐條核對來源；未經公司審閱。",
 "url": "https://drugnews.com.tw/companies/tw-6564.json",
 "generated_at": "2026-10-23T11:48:56.615Z"
}